SCHEMBL23584632

SCHEMBL23584632

CN1CCC2(C1)CN(CC1CCC(n3cnc4c(N)ncnc43)O1)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 4/20 0.48
▸ WDR77 Q9BQA1 4/20 0.48
▸ PI4K2A Q9BTU6 5/20 0.45
▸ PI4KA P42356 4/20 0.45
▸ PI4K2B Q8TCG2 4/20 0.45
▸ PI4KB Q9UBF8 4/20 0.45
▸ TP53 P04637 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ APEX1 P27695 1/20 0.45
▸ BLM P54132 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ ADCY1 Q08828 1/20 0.45
▸ BCHE P06276 1/20 0.44
▸ ADA P00813 1/20 0.44
▸ ADORA2A P29274 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23584573 0.95 PRMT5 (0.51) PRMT5WDR77PI4K2API4KAPI4K2B
SCHEMBL19344583 0.95 PRMT5 (0.49) PRMT5WDR77PI4K2API4KAPI4K2B
SCHEMBL23584750 0.94 PRMT5 (0.50) PRMT5WDR77PI4K2API4KAPI4K2B
SCHEMBL23584824 0.94 PRMT5 (0.52) PRMT5WDR77PI4K2API4KAPI4K2B
SCHEMBL23584782 0.92 PRMT5 (0.54) PRMT5WDR77PI4K2API4KAPI4K2B
SCHEMBL23584804 0.91 PRMT5 (0.54) PRMT5WDR77PI4K2API4KAPI4K2B
SCHEMBL23584728 0.85 BCHE (0.46) PRMT5WDR77PI4K2API4KAPI4K2B
SCHEMBL23584811 0.85 PRMT5 (0.50) PRMT5WDR77PI4K2API4KAPI4K2B
SCHEMBL22434821 0.85 PRMT5 (0.60) PRMT5WDR77PI4K2API4KAPI4K2B
SCHEMBL23584501 0.84 PI4KA (0.49) PRMT5WDR77PI4K2API4KAPI4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426664-B1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-06-30 — — EP disclosed
Send feedback